A/Prof Ford co-leads the complex PCI (stent) program locally at Central Coast Local Health District and his main clinical focus is minimally invasive cardiac procedures particularly in high-risk patients and the elderly.

He is passionate about complex coronary disease and is a proctor for rotablation (calcium drilling) regularly performing lists on patients too high risk for open heart surgery. He is a registered Australian TAVI practitioner with expertise in

– Chest pain (angina) and breathlessness

– Heart attacks

– Heart failure

– Heart valve disease (e.g. aortic stenosis)

– Structural heart interventions including TAVI, percutaneous closure of patent foramen ovale (PFO) /atrial septal defects (ASD).

- Chronic total occlusions (CTO)

- complex long-term blockages.

Tom is an invited speaker and faculty at leading national and international cardiology scientific sessions including EuroPCR, Transcatheter Cardiovascular Therapeutics (TCT in USA) and European Society of Cardiology (ESC congress). His research has been published in the most influential cardiology journals and was recently recognized with two prestigious accolades firstly from the European wide PCR organization (EuroPCR Best Abstract – Winner PCR’s got talent) and secondly from the British Cardiac Society (‘Best of the Best’ Clinical Abstract – Interventional Cardiology).

A/Prof Ford emigrated to Australia 10 years ago after gaining the MRCP at the Royal College of Physicians in Edinburgh. He qualified as a Cardiologist in 2015 (FRACP) after completing advanced Cardiology training in Sydney (Prince of Wales Hospital and St George Hospitals). In 2019, A/Prof Ford returned from three additional years of fellowship and training in Glasgow (Golden Jubilee National Hospital). This centre has the largest volume of coronary stent procedures in the UK. His training in two continents over eight years exposed him to a high volume of Interventional Cardiology procedures including complex stenting, emergency care of heart attacks and patients in shock, structural heart interventions and novel invasive treatments including those for resistant hypertension.

During his time in Glasgow, he led clinical research projects into coronary heart disease leading internationally recognised clinical trials with state-of-the-art invasive testing and personalised treatment for angina patients. This work is directly relevant to help diagnose and improve quality of life for patients with angina, chest pain and/or breathlessness. His PhD was submitted in 2019 to the University of Glasgow and won the Bellahouston Medal as the highest distinction for the excellence of theses submitted for the degrees of MD, DDS and PhD. He is an Honorary Clinical Lecturer at the University of Glasgow and an Honorary Conjoint Associate at the University of New South Wales, Sydney.